Impact BioMedical, Inc. (IBO)
0.629
0.00 (0.00%)
USD |
NYAM |
May 08, 16:00
0.6271
0.00 (0.00%)
After-Hours: 20:00
Impact BioMedical EPS Diluted (Quarterly) : 0.0501 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.2625 |
| IGC Pharma, Inc. | -0.0076 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.235M |
| Revenue (Quarterly) | 0.007M |
| Total Expenses (Quarterly) | -5.238M |
| Enterprise Value | 70.76M |
| Gross Profit Margin (Quarterly) | -10.01K% |
| Earnings Yield | -215.1% |
| Normalized Earnings Yield | -98.51 |